Skip to main content
Clinical Trials/EUCTR2011-002135-26-IT
EUCTR2011-002135-26-ITActive, not recruitingNot Applicable

Efficacy and Safety of Acyclovir 5 Lipstick (Contra) in Treatment of Skin Infections Provoked by Herpes Simplex. A Randomised, Double-blind, Placebo Controlled, Parallel Group Study. - 4PH/2011/002

AESCULAPIUS FARMACEUTICI S.R.L.0 sitesStarted: December 27, 2011Last updated:
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • - Caucasian origin; - Patients with a clinical diagnosis of active infection of recurrent labial herpes in prodromal phase; - Body weight within 20% of ideal body weight; - Normal physical examination, vital signs, ECG; - Negative result of pregnancy test for female patients.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

  • ? Recent infection of Herpes Zoster in the last 4 weeks; ? Treatment with other systemic or topical antiviral agents or systemic corticosteroids within 4 weeks prior to study drug administration; ? Previous herpes vaccine; ? Pregnant, nursing and/or lactating females; ? Patients with herpetic stomatitis; ? Patients with severe symptoms or signs of herpes labialis such as intraoral lesions or lesions in the nostrils; - Subjects with lesions wider than 2.0cm2; - Subjects with renal, hepatic or metabolic dysfunction that may pose a risk to the safety;

Investigators

Sponsor
AESCULAPIUS FARMACEUTICI S.R.L.

Similar Trials